Oestrogen promotes the progression of adenomyosis by inhibiting CITED2 through miR-145
Lab / animal
OA: closed
CC0
AI-generated summary
This study investigated how oestrogen drives adenomyosis progression by downregulating CITED2 expression via miR-145.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
RESEARCH QUESTION: Is the microRNA miR-145 involved in adenomyosis, and by what mechanisms does it affect disease development and is itself regulated?
DESIGN: Fluorescence in-situ hybridization was used to observe the expression pattern of miR-145 in adenomyosis ectopic endometrium (n = 13), adenomyosis eutopic endometrium (n = 15) and non-adenomyosis eutopic endometrium (n = 14). RNA sequencing was used to screen target genes as well as downstream pathways of miR-145, which were validated by reporter gene assay, quantitative polymerase chain reaction and western blot, and further analysed using cell migration assay and chromatin immunoprecipitation assay.
RESULTS: The fluorescence in-situ hybridization assay revealed a noteworthy elevation in miR-145 expression in adenomyosis tissue compared with non-adenomyosis tissue. Furthermore, RNA sequencing analysis revealed that overexpression of miR-145 resulted in heightened expression of genes associated with the cytokine signalling pathway, nucleotide-binding and oligomerization domain-like pathway and adhesion pathway, including IL-1β and IL-6. Our study has identified CITED2 as a downstream direct target gene of miR-145, which is implicated in the inhibition of stromal cell migration induced by miR-145. Moreover, chromatin immunoprecipitation was used to validate the direct effect of oestradiol on the promoter region of miR-145, mediated by oestrogen receptor α, which facilitates the upregulation of miR-145 expression.
CONCLUSION: Our findings provide evidence supporting the role of oestradiol, acting through its receptor α, in modulating the discovered miR-145-CITED2 signalling axis, thereby promoting the progression of adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (50)
- Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis via openalex
- Clinical practice. Endometriosis via openalex
- Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model via openalex
- IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth Factors via openalex
- miR-218-5p in endometrial microenvironment prevents the migration of ectopic endometrial stromal cells by inhibiting LASP1 via openalex
- miR-31 and miR-145 as Potential Non-Invasive Regulatory Biomarkers in Patients with Endometriosis via openalex
- Pathogenesis Based Diagnosis and Treatment of Endometriosis via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- The role of inflammation, oxidative stress, angiogenesis, and apoptosis in the pathophysiology of endometriosis: Basic science and new insights based on gene expression via openalex
- The role of microRNAs in endometriosis and associated reproductive conditions via openalex
- TNFα-Induced Altered miRNA Expression Links to NF-κB Signaling Pathway in Endometriosis via openalex
- Update on endometriosis pathogenesis via openalex
- Uterine adenomyosis: pathogenesis, diagnostics, symptomatology and treatment via openalex
- W2112835707 via openalex
- W2125887885 via openalex
- W2141948830 via openalex
- W2145487094 via openalex
- W2145571102 via openalex
- W2154448714 via openalex
- W2156066970 via openalex
- W2171589804 via openalex
- W2515052691 via openalex
- W2772861029 via openalex
- W2774365345 via openalex
- W2805876954 via openalex
- W2899117337 via openalex
- W2900597665 via openalex
- W2997095491 via openalex
- W3027309119 via openalex
- W3134885188 via openalex
- W4210297491 via openalex
- W4234160457 via openalex
- W4324370650 via openalex
- W6736467252 via openalex
- W6769966610 via openalex
- W6770759602 via openalex
- W267375853 via openalex
- W6773180998 via openalex
- W1590222977 via openalex
- W1908209720 via openalex
- W1965306643 via openalex
- W1975545468 via openalex
- W1992254250 via openalex
- W2004232360 via openalex
- W2008945738 via openalex
- W2038362499 via openalex
- W2045571416 via openalex
- W2059117644 via openalex
- W2076246431 via openalex
- W2111663113 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-10-10T06:11:15.153948+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-10T06:07:53.304686+00:00
- unpaywall
- last seen: 2026-10-10T06:25:47.132674+00:00
License: CC0
· commercial use OK